UNSPSC 51391719: Etafedrine

This classification denotes a beta-adrenergic agonist with the molecular formula C12H19NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Y6VQU63E8, chemically known as benzyl alcohol, alpha-(1-(ethylmethylamino)ethyl)- but generally known as etafedrine, which bears US NIH Compound Identifier 10734. European Medicines Agency schedules Etafedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07256MIG. The term ETAFEDRINE is an International Non-Proprietary Name.

UNSPSC 51391719 Etafedrine is a Commodity code with minimal recent state and local procurement activity. The single recent opportunity posted under this code — Seminole County, Florida's IFB for Naloxone and Drug Deactivation Systems — involves the purchase of naloxone units and safe drug deactivation systems rather than etafedrine itself, suggesting a mismatch between the code assignment and the actual procurement scope. The opportunity does reflect state and local government investment in opioid-response and community health infrastructure, but the code shows little relevant recent activity aligned with its nominal pharmaceutical product.

Seminole County issued the invitation for bid (IFB60459723LAS) on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement requires E-Verify compliance, drug-free workplace certification, and standard commercial insurance including workers' compensation and general liability. The contract term is two years with an optional one-year renewal on a fixed-fee basis, with bidders responsible for all shipping and delivery costs. Given the code's narrow recent activity and the apparent misalignment between the etafedrine commodity designation and the naloxone-focused procurement actually posted, this code warrants low priority for business development unless your firm specializes in pharmaceutical products that states and local jurisdictions purchase under different UNSPSC classifications.